|
|
|
|
Genome Res. 15:820-829, 2005 ©2005 by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/05 $5.00 Letter Genome-scale analysis of Streptomyces coelicolor A3(2) metabolism1 Center for Microbial Biotechnology, BioCentrum-DTU, Technical University of Denmark, DK-2800 Lyngby, Denmark 2 Department of Biochemical Engineering, University College London, WC1E7JE London, United Kingdom
Streptomyces are filamentous soil bacteria that produce more than half of the known microbial antibiotics. We present the first genome-scale metabolic model of a representative of this groupStreptomyces coelicolor A3(2). The metabolism reconstruction was based on annotated genes, physiological and biochemical information. The stoichiometric model includes 819 biochemical conversions and 152 transport reactions, accounting for a total of 971 reactions. Of the reactions in the network, 700 are unique, while the rest are iso-reactions. The network comprises 500 metabolites. A total of 711 open reading frames (ORFs) were included in the model, which corresponds to 13% of the ORFs with assigned function in the S. coelicolor A3(2) genome. In a comparative analysis with the Streptomyces avermitilis genome, we showed that the metabolic genes are highly conserved between these species and therefore the model is suitable for use with other Streptomycetes. Flux balance analysis was applied for studies of the reconstructed metabolic network and to assess its metabolic capabilities for growth and polyketides production. The model predictions of wild-type and mutants' growth on different carbon and nitrogen sources agreed with the experimental data in most cases. We estimated the impact of each reaction knockout on the growth of the in silico strain on 62 carbon sources and two nitrogen sources, thereby identifying the "core" of the essential reactions. We also illustrated how reconstruction of a metabolic network at the genome level can be used to fill gaps in genome annotation.
Streptomycetes are soil-inhabiting Gram-positive bacteria belonging to the order of Actinomycetales (Garrity 2002
Streptomyces coelicolor A3(2) is by far the best genetically studied Streptomyces strain and has become a model organism for Streptomyces species (Hopwood 1999
At the present, metabolic networks have been reconstructed for several bacteria (e.g., Escherichia coli) (Edwards and Palsson 2000b Here, the reconstructed metabolic network of S. coelicolor A3(2) is applied for detailed study of the organism's metabolism.
Reconstruction and characteristics of the metabolic network Reconstruction of high-quality and well-annotated metabolic networks is laborious as information needs to be acquired from many different sources. The reconstruction can be facilitated by software, for example, PathoLogic (Karp et al. 2002
Modeling of S. coelicolor A3(2) is a challenging task because of the complexity of this filamentous bacteria. Its genome size of 8,667,507 bp is unusually large for bacteria sequenced to date. Out of 7825 predicted open reading frames (ORFs), a function has been assigned to 5492, which also includes broad definitions such as "putative membrane protein," "putative transmembrane transport protein," and similar ones (S.D. Bentley, pers. comm). It is estimated that 965 proteins have a regulatory function, 819 proteins are secreted (these include numerous hydrolytic enzymes), 614 proteins participate in transport, and 22 gene clusters are involved in secondary metabolites production (Bentley et al. 2002
Universality of the S. coelicolor A3(2) model We estimated the possibility of extrapolating the use of the S. coelicolor A3(2) metabolic network for other Streptomyces strains by comparing the genomes of S. coelicolor A3(2) and S. avermitilis (Supplemental Data Set 4). In total, 53% of the genes in S. coelicolor A3(2) are synteny conserved with Streptomyces avermitilis, that is, their relative position in the genome has been retained throughout evolution of these two Streptomyces strains; 35% of the S. coelicolor A3(2) genes have orthologs whose position is not conserved in S. avermitilis; only 12% of the genes do not have an ortholog in S. avermitilis. Out of 711 ORFs included in the model, 78% are synteny conserved with S. avermitilis, which shows that there is a much higher degree of synteny for metabolic genes than for the other genes. A further 22% of the ORFs in the metabolic model are coding for isoenzymes of which at least one synteny-conserved ORF is present in S. avermitilis. The high fraction of synteny-conserved ORFs and isoenzymes in the model indicates that the S. coelicolor A3(2) metabolic network can be used as a starting point for a rapid reconstruction of the reaction networks for other Streptomyces species.
Connectivity
Growth energetics
which states that for a pseudo-steady state, the rate of ATP production rATP is equal to the ATP consumption for growth YxATP · µ and maintenance mATP, where µ is the specific growth rate and YxATP is the ATP yield coefficient (Stouthamer and Bettenhaussen 1973
Reactions activity
Interestingly, some of the enzymes that catalyze "dead-end" reactions in the model have been detected on 2D gels in S. coelicolor A3(2) grown on a minimal medium supplemented with casamino acids (http://dbkweb.ch.umist.ac.uk/StreptoBASE/s_coeli/referencegel/). One of the enzymes was putative mannose-1-phosphate guanyltransferase (SCO1388), which is known to be involved in mannosylation of proteins, a common protein modification for Actinomycetes. The reaction appears as a dead end in the model because protein modifications are not included in the reactions list, and therefore the GDP-activated mannose-1-phosphate is not used in any other reactions. Another enzyme is 2-dehydro-3-deoxyphosphogluconate aldolase/4-hydroxy-2-oxoglutarate aldolase (SCO0852), which is either involved in Entner-Doudoroff (ED) pathway [this is unlikely as the characteristic ED pathway gene edd was not found in the genome sequence of Streptomyces coelicolor A3(2)] or is responsible for inter-converting 4-hydroxy- -ketoglutarate into glyoxylate and pyruvate. Experimental evidence has been obtained that the enzyme is important in regulation of glyoxylate levels in the cells of E. coli (Cayrol et al. 1995 -ketoglutarate dehydrogenase complex and results in pyruvate-catalyzed oxidation of glyoxylate into malyl-CoA (Gupta and Dekker 1984
Reactions dispensability We studied dispensability of the reactions in the network by making single reaction deletions and optimizing for growth on 62 different C-sources and two different inorganic N-sources (ammonia and nitrate, only tested with glucose as C-source). The approach differs from single gene deletion studies, because if isoenzymes are present, then their simultaneous knockout will be simulated by deleting the reaction they catalyze. We find this approach more informative for studying the sensitivity of the metabolic network to perturbations. To quantify the effect of reaction deletion, we defined reaction essentiality as the relative decrease in the specific growth rate with deletion of the reaction in comparison to the specific growth rate with the complete reaction set (2):
that is, the reaction essentiality is 1 for an essential reaction, whereas it is 0 for a reaction that upon removal has no growth-retarding effect. The reaction essentialities for the growth on glucose and ammonia are shown in Figure 5A, and Figure 5B illustrates the summed reaction essentialities for growth on the 63 different media (Supplemental Data Set 9). Reactions with a summed reaction essentiality of 63 are required for growth under all the defined conditions, and hence are true essential reactions. The reactions that have a summed reaction essentiality lower than 63 are either necessary only under certain conditions or their deletion leads to growth retardation. The comparison of Figure 5A and Figure 5B shows that the choice of conditions is important for defining the dispensability of reactions. While during growth on glucose and ammonia 64% of the reactions could be eliminated without any consequences for cellular growth, several of these reactions turned out to be essential for growth on other C-sources than glucose, and the number of nonessential deletions was reduced from 64% to 39% when all the growth conditions were considered. The minimal metabolic net, necessary for growth under all the conditions, consists of 146 reactions. Considering that 17% of them have an isoenzyme, there are basically 121 metabolic genes that are truly essential (e.g., essential on the complete medium), which corresponds to 12% of the original metabolic network. Essential and nonessential reactions were found to have almost equal occurrence of isoenzymes (17% and 15%, respectively), whereas a higher fraction of the growth-retarding or conditionally essential reactions were catalyzed by isoenzymes (26%). This undermines a hypothesis that isoenzymes exist to increase the robustness of the metabolic network to mutations.
Metabolic capabilities of the network Degradation of carbon and nitrogen sources In most cases the model correctly predicted growth capability on various C-sources and N-sources for S. coelicolor A3(2) wild type and mutant (Table 3). There was a disagreement on usage of aspartate and glutamine as the sole C-source, which was possible according to the model, but has not been observed experimentally. It is known than S. coelicolor A3(2) can grow on asparagine, which is presumably degraded via aspartate. In this case, it may be regulatory events that do not allow aspartate utilization rather than the lack of metabolic capacity. S. coelicolor A3(2) can use glutamine as the sole N-source, but not as C-source, while glutamate can be used as both. There is evidence that glutamate is decarboxylated into -aminobutanoate upon the uptake (Inbar and Lapidot 1991
The deletions of trpC1 and trpD1 in S. coelicolor A3(2) result in auxotrophy for tryptophan, because the genes with analogical functionstrpC2 and trpD2are located in the calcium-dependent antibiotic biosynthetic cluster and apparently can be used exclusively in the secondary metabolism (Hu et al. 1999 The described inconsistencies can be resolved in the future by expanding the model to include regulatory constraints.
Biomass yield
Anaerobic growth
We analyzed the problem from the perspective of the reconstructed metabolic network and did not find any essential reactions that exclusively use oxygen. It seems that the essential dehydroorotate dehydrogenase E.C. 1.3.3.1 [EC] (SCO1482) required for pyrimidines biosynthesis and L-aspartate oxidase E.C. 1.4.3.16 [EC] (SCO3382) participating in nicotinamide nucleotides biosynthesis can both use oxygen and menaquinone as electron acceptors. Anaerobic growth can simply require that the produced menaquinol can be reoxidized by the reverse action of succinate dehydrogenase. When glucose uptake rate was set to the maximal experimentally observed value (2.2 mmol/g DW/h) (Melzoch et al. 1997
Actinorhodin production
Filling the gaps in genome annotation
If any of these conditions were not fulfilled, a missing reaction(s) was added according to the pathway structure (organism specific or general if the former was not available). A total of 205 reactions without assigned ORFs were added to the model: 79 enzymatic reactions, 117 transport reactions, five spontaneous, and four artificial reactions like maintenance and biomass assembly (Supplemental Data Set 10). Out of the 79 enzymatic reactions, 27 were identified as being essential for growth on glucose and salts. In the context of functional genomics, the reconstructed metabolic network hence serves as physiological evidence for the presence of these genes and allows directed search for the ORFs with the necessary function. Each of these 27 reactions was subsequently analyzed on an individual basis. The genome was searched for genes with specific protein motifs (http://www.sanger.ac.uk/Software/Pfam/), and the obtained hits were evaluated using the functions of the neighboring genes and their possible organization in an operon. The previously described Bayesian method (Green and Karp 2004
Phospholipids biosynthesis
Polyprenoids biosynthesis The annotation of the polyprenoid biosynthesis was re-examined because five essential genes were found to be missing in the KEGG database, that is, (E)-4-hydroxy-3-methylbut-2-enyl diphosphate reductase (IspH/LytB), pentaprenyl diphosphate synthase, hexaprenyl diphosphate synthase, octaprenyl diphosphate synthase, and nonaprenyl diphosphate synthase. The enzymes involved in the polyprenoid biosynthesis all have a prenyltransferase domain IPR001441. S. coelicolor A3(2) contains seven genes with a polyprenyltransferase domain, that is, SCO0185, SCO0565, SCO0568, SCO2509, SCO3858, SCO4583, SCO5250, and SCO6763. Two of the genes, SCO2509 and SCO3858, are synteny conserved with M. tuberculosis and must therefore have an important function. Furthermore SCO0185, SCO4583, SCO5250, and SCO6763 are synteny conserved with S. avermitilis. These six conserved genes are likely to be involved in general polyprenoid biosynthesis. The SCO0185 (crtB) is involved in biosynthesis of a secondary carotenoid metabolite (Lee et al. 2001 ,E,Z-farnesyl diphosphate synthase (Schulbach et al. 2000
We have reconstructed the metabolic network of S. coelicolor A3(2). Besides resulting in improved annotation of several genes and suggestions for annotation of other genes, the reconstructed network may be used as a model of the metabolism in Streptomyces. Earlier attempts to model Streptomyces spp. (Avignone et al. 2002
Reconstruction process For reconstruction of the S. coelicolor A3(2) metabolic network, we used the annotated genome databases (KEGG PATHWAY database: http://www.genome.ad.jp/dbget-bin/get_htext?S.coelicolor.kegg+-f+T+w+C and The Wellcome Trust Sanger Institute database: http://www.sanger.ac.uk/Projects/S_coelicolor/scheme.shtml), metabolic databases (KEGG Ligand database: http://www.genome.ad.jp/kegg/ligand.html; ExPASy Biochemical Pathways: http://www.expasy.org/cgi-bin/search-biochem-index; ExPASy Enzyme Database: http://www.expasy.org/enzyme; SWISS-PROT database: http://www.expasy.org/sprot/sprot-top.html), biochemistry books (Ingraham et al. 1983
Modeling
where
As the number of metabolic fluxes exceeded the number of mass balance constraints, there existed a set of feasible metabolic fluxes distributions. A solution was found using linear programming by introducing an optimization problem: MAXIMIZE Z = c · For simulations of growth, the flux to biomass was set to a certain value and the substrate uptake rate was minimized. For simulation of antibiotic production, the substrate uptake rate was constrained and the flux toward the antibiotic was maximized. In order to find fluxes that were active during alternative optimal solutions, the following algorithm was used:
The calculations were performed using the commercially available linear programming package LINDO (Lindo Systems Inc.). The algorithm for finding fluxes that are active during alternative optimal solutions was implemented in Matlab (The MathWorks Inc.), but the LINDO package was used as the solver for the linear programming problems.
Estimation of energetic parameters The YxATP is composed of three parts:
The last composite YxATP_growth_maintenance as well as maintenance ATP (mATP) were not known and were estimated from the experimental chemostate data (Melzoch et al. 1997 Normally the glucose uptake rate qgluc, carbon dioxide production rate qCO2 and oxygen uptake rate qO2 are linearly dependent on the specific growth rate (Fig. 3). The YxATP_growth_maintenance and mATP were set up to arbitrary values, and the simulations were run for each of the experimentally investigated dilution rates by fixing the specific growth rate and actinorhodin production rate to the experimental values and performing linear optimization for glucose uptake rate minimization (Supplemental Data Set 6). The obtained qgluc, qCO2 and qO2 dependence on dilution rate was compared to the experimental rate. The YxATP_growth_maintenance and mATP were changed until a good prediction was obtained. For the further simulations, the maximal P/O ratio was fixed to 1.5 and YxATP and mATP were set to the corresponding values.
We thank D.A. Hodgson for providing his Ph.D. thesis and for the excellent review on the primary metabolism of Streptomyces. We are grateful to Jochen Förster for sharing his experience in genome-scale modeling.
3 Corresponding author. E-mail jn{at}biocentrum.dtu.dk; fax 45 4588 4148. [Supplemental material is available online at www.genome.org.] Article and publication are at http://www.genome.org/cgi/doi/10.1101/gr.3364705.
Avignone, R.C., White, J., Kuiper, A., Postma, P.W., Bibb, M., and Teixeira de Mattos, M.J. 2002. Carbon flux distribution in antibiotic-producing chemostat cultures of Streptomyces lividans. Metab. Eng. 4: 138-150.[CrossRef][Medline] Barona-Gomez, F. and Hodgson, D.A. 2003. Occurrence of a putative ancient-like isomerase involved in histidine and tryptophan biosynthesis. EMBO Rep. 4: 296-300.[CrossRef][Medline] Bentley, S.D., Chater, K.F., Cerdeno-Tarraga, A.M., Challis, G.L., Thomson, N.R., James, K.D., Harris, D.E., Quail, M.A., Kieser, H., Harper, D., et al. 2002. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature 417: 141-147.[CrossRef][Medline]
Blanco, J., Coque, J.J., and Martin, J.F. 1998. The folate branch of the methionine biosynthesis pathway in Streptomyces lividans: Disruption of the 5,10-methylenetetrahydrofolate reductase gene leads to methionine auxotrophy. J. Bacteriol. 180: 1586-1591. Bott, M. and Niebisch, A. 2003. The respiratory chain of Corynebacterium glutamicum. J. Biotechnol. 104: 129-153.[CrossRef][Medline] Bruheim, P., Butler, M., and Ellingsen, T.E. 2002. A theoretical analysis of the biosynthesis of actinorhodin in a hyper-producing Streptomyces lividans strain cultivated on various carbon sources. Appl. Microbiol. Biotechnol. 58: 735-742.[CrossRef][Medline] Bucca, G., Brassington, A.M., Hotchkiss, G., Mersinias, V., and Smith, C.P. 2003. Negative feedback regulation of dnaK, clpB and lon expression by the DnaK chaperone machine in Streptomyces coelicolor, identified by transcriptome and in vivo DnaK-depletion analysis. Mol. Microbiol. 50: 153-166.[CrossRef][Medline] Burgard, A.P., Pharkya, P., and Maranas, C.D. 2003. Optknock: A bilevel programming framework for identifying gene knockout strategies for microbial strain optimization. Biotechnol. Bioeng. 84: 647-657.[CrossRef][Medline]
Cayrol, C., Petit, C., Raynaud, B., Capdevielle, J., Guillemot, J.C., and Defais, M. 1995. Recovery of respiration following the SOS response of Escherichia coli requires RecA-mediated induction of 2-keto-4-hydroxyglutarate aldolase. Proc. Natl. Acad. Sci. 92: 11806-11809. Covert, M.W., Knight, E.M., Reed, J.L., Herrgard, M.J., and Palsson, B.Ø. 2004. Integrating high-throughput and computational data elucidates bacterial networks. Nature 429: 92-96.[CrossRef][Medline]
Duarte, N.C., Herrgard, M.J., and Palsson, B.Ø. 2004. Reconstruction and validation of Saccharomyces cerevisiae iND750, a fully compartmentalized genome-scale metabolic model. Genome Res. 14: 1298-1309. Edwards, J.S. and Palsson, B.Ø. 2000a. Metabolic flux balance analysis and the in silico analysis of Escherichia coli K-12 gene deletions. BMC Bioinformatics 1: 1.[CrossRef][Medline]
____. 2000b. The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities. Proc. Natl. Acad. Sci. 97: 5528-5533. Edwards, J.S., Ibarra, R.U., and Palsson, B.Ø. 2001. In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data. Nat. Biotechnol. 19: 125-130.[CrossRef][Medline]
Famili, I., Förster, J., Nielsen, J., and Palsson, B.Ø. 2003. Saccharomyces cerevisiae phenotypes can be predicted by using constraint-based analysis of a genome-scale reconstructed metabolic network. Proc. Natl. Acad. Sci. 100: 13134-13139.
Fink, D., Falke, D., Wohlleben, W., and Engels, A. 1999. Nitrogen metabolism in Streptomyces coelicolor A3(2): Modification of glutamine synthetase I by an adenylyltransferase. Microbiology 145: 2313-2322. Flett, F., Platt, J., and Cullum, J. 1987. DNA rearrangements associated with instability of an arginine gene in Streptomyces coelicolor A3(2). J. Basic Microbiol. 27: 3-10.[Medline]
Förster, J., Famili, I., Fu, P., Palsson, B.Ø., and Nielsen, J. 2003a. Genome-scale reconstruction of the Saccharomyces cerevisiae metabolic network. Genome Res. 13: 244-253. Förster, J., Famili, I., Palsson, B.Ø., and Nielsen, J. 2003b. Large-scale evaluation of in silico gene deletions in Saccharomyces cerevisiae. OMICS 7: 193-202.[CrossRef][Medline] Garrity, G.M. 2002. Bergey's manual of systematic bacteriology. Springer-Verlag, New York. Green, M.L. and Karp, P.D. 2004. A Bayesian method for identifying missing enzymes in predicted metabolic pathway databases. BMC Bioinformatics 5: 76.[CrossRef][Medline]
Gupta, S.C. and Dekker, E.E. 1984. Malyl-CoA formation in the NAD-, CoASH-, and Hesketh, A.R., Chandra, G., Shaw, A.D., Rowland, J.J., Kell, D.B., Bibb, M.J., and Chater, K.F. 2002. Primary and secondary metabolism, and post-translational protein modifications, as portrayed by proteomic analysis of Streptomyces coelicolor. Mol. Microbiol. 46: 917-932.[CrossRef][Medline] Hockenhull, D.J., Fantes, K.H., Herbert, M., and Whitehead, B. 1954. Glucose utilization by Streptomyces griseus. J. Gen. Microbiol. 10: 353-370.[Medline] Hodgson, D.A. 1980. "Carbohydrate utilization in Streptomyces coelicolor A3(2)." Ph.D thesis, University of East Anglia, Norwich, UK. ____. 2000. Primary metabolism and its control in Streptomycetes. Adv. Microbial Physiol. 42: 47-238.[Medline]
Hopwood, D.A. 1999. Forty years of genetics with Streptomyces: From in vivo through in vitro to in silico. Microbiology 145: 2183-2202. Hu, D.S., Hood, D.W., Heidstra, R., and Hodgson, D.A. 1999. The expression of the trpD, trpC and trpBA genes of Streptomyces coelicolor A3(2) is regulated by growth rate and growth phase but not by feedback repression. Mol. Microbiol. 32: 869-880.[CrossRef][Medline]
Huang, G., Lih, C.-J., Pan, K.-H., and Cohen, S.N. 2001. Global analysis of growth phase responsive gene expression and regulation of antibiotic biosynthetic pathways in Streptomyces coelicolor using DNA microarrays. Genes & Dev. 15: 3183-3192.
Ideker, T., Thorsson, V., Ranish, J.A., Christmas, R., Buhler, J., Eng, J.K., Bumgarner, R., Goodlett, D.R., Aebersold, R., and Hood, L. 2001. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 292: 929-934.
Ihmels, J., Bergmann, S., and Barkai, N. 2004. Defining transcription modules using large-scale gene expression data. Bioinformatics 20: 1993-2003.
Inbar, L. and Lapidot, A. 1991. 13C nuclear magnetic resonance and gas chromatography-mass spectrometry studies of carbon metabolism in the actinomycin D producer Streptomyces parvulus by use of 13C-labeled precursors. J. Bacteriol. 173: 7790-7801. Ingraham, J.L., Maaløe, O., and Neidhardt, F.C. 1983. Growth of the bacterial cell. Sinauer, Sunderland, MA.
Jackson, M., Crick, D.C., and Brennan, P.J. 2000. Phosphatidylinositol is an essential phospholipid of mycobacteria. J. Biol. Chem. 275: 30092-30099. Karp, P.D., Paley, S., and Romero, P. 2002. The Pathway Tools software. Bioinformatics 18: S225-S232.[Abstract]
Kealey, J.T., Liu, L., Santi, D.V., Betlach, M.C., and Barr, P.J. 1998. Production of a polyketide natural product in nonpolyketide-producing prokaryotic and eukaryotic hosts. Proc. Natl. Acad. Sci. 95: 505-509. Kell, D.B. 2004. Metabolomics and systems biology: Making sense of the soup. Curr. Opin. Microbiol. 7: 296-307.[CrossRef][Medline] Kennedy, J., Murli, S., and Kealey, J.T. 2003. 6-Deoxyerythronolide B analogue production in Escherichia coli through metabolic pathway engineering. Biochemistry 42: 14342-14348.[CrossRef][Medline] Kieser, T., Bibb, M.J., Buttner, M.J., Chater, K.F., and Hopwood, D.A. 2000. General introduction to actinomycete biology. In Practical Streptomyces genetics, pp. 1-42. The John Innes Foundation, Norwich, UK. Kinoshita, K., Pfeifer, B.A., Khosla, C., and Cane, D.E. 2003. Precursor-directed polyketide biosynthesis in Escherichia coli. Bioorg. Med. Chem. Lett. 13: 3701-3704.[CrossRef][Medline]
Lee, H.S., Ohnishi, Y., and Horinouchi, S. 2001. A Melzoch, K., Teixeira de Mattos, M.J., and Neijssel, O.M. 1997. Production of actinorphodin by Streptomyces coelicolor A3(2) grown in chemostat culture. Biotech. Bioengineer. 54: 577-582. Michal, G. 1999. Biochemical pathways: An atlas of biochemistry and molecular biology. Wiley, New York. Navarrete, R.M., Vara, J.A., and Hutchinson, C.R. 1990. Purification of an inducible L-valine dehydrogenase of Streptomyces coelicolor A3(2). J. Gen. Microbiol. 136: 273-281.[Medline] Novotna, J., Vohradsky, J., Berndt, P., Gramajo, H., Langen, H., Li, X.M., Minas, W., Orsaria, L., Roeder, D., and Thompson, C.J. 2003. Proteomic studies of diauxic lag in the differentiating prokaryote Streptomyces coelicolor reveal a regulatory network of stress-induced proteins and central metabolic enzymes. Mol. Microbiol. 48: 1289-1303.[CrossRef][Medline] Pandya, K.P. and King, H.K. 1966. Ubiquinone and menaquinone in bacteria: A comparative study of some bacterial respiratory systems. Arch. Biochem. Biophys. 114: 154-157.[CrossRef][Medline] Papp, B., Pal, C., and Hurst, L.D. 2004. Metabolic network analysis of the causes and evolution of enzyme dispensability in yeast. Nature 429: 661-664.[CrossRef][Medline] Poralla, K., Muth, G., and Hartner, T. 2000. Hopanoids are formed during transition from substrate to aerial hyphae in Streptomyces coelicolor A3(2). FEMS Microbiol. Lett. 189: 93-95.[CrossRef][Medline] Reed, J.L., Vo, T.D., Schilling, C.H., and Palsson, B.Ø. 2003. An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR). Genome Biol. 4: R54.[CrossRef][Medline] Roubos, H. 2002. "Bioprocess modeling and optimization. Fed-batch clavulanic acid production by Streptomyces clavuligerus." Ph.D thesis, Delft University of Technology, Ponsen & Looijen, Netherlands. Schilling, C.H. and Palsson, B.Ø. 2000. Assessment of the metabolic capabilities of Haemophilus influenzae Rd through a genome-scale pathway analysis. J. Theor. Biol. 203: 249-283.[CrossRef][Medline] Schilling, C.H., Edwards, J.S., and Palsson, B.Ø. 1999. Toward metabolic phenomics: Analysis of genomic data using flux balances. Biotechnol. Prog. 15: 288-295.[CrossRef][Medline]
Schilling, C.H., Covert, M.W., Famili, I., Church, G.M., Edwards, J.S., and Palsson, B.Ø. 2002. Genome-scale metabolic model of Helicobacter pylori 26695. J. Bacteriol. 184: 4582-4593.
Schulbach, M.C., Brennan, P.J., and Crick, D.C. 2000. Identification of a short (C15) chain Z-isoprenyl diphosphate synthase and a homologous long (C50) chain isoprenyl diphosphate synthase in Mycobacterium tuberculosis. J. Biol. Chem. 275: 22876-22881. Shahab, N., Flett, F., Oliver, S.G., and Butler, P.R. 1996. Growth rate control of protein and nucleic acid content in Streptomyces coelicolor A3(2) and Escherichia coli B/r. Microbiology 142: 1927-1935.[Abstract] Stanier, R.Y., Ingraham, J.L., Wheelis, M.L., and Painter, P.R. 1986. General microbiology, 5th ed. Macmillan Education LTD, London. Stelling, J., Klamt, S., Bettenbrock, K., Schuster, S., and Gilles, E.D. 2002. Metabolic network structure determines key aspects of functionality and regulation. Nature 420: 190-193.[CrossRef][Medline] Stouthamer, A.H. and Bettenhaussen, C. 1973. Utilization of energy for growth and maintenance in continuous and batch cultures of microorganisms. A reevaluation of the method for the determination of ATP production by measuring molar growth yields. Biochim. Biophys. Acta 301: 53-70.[Medline]
Tang, L. and Hutchinson, C.R. 1993. Sequence, transcriptional, and functional analyses of the valine (branched-chain amino acid) dehydrogenase gene of Streptomyces coelicolor. J. Bacteriol. 175: 4176-4185. Thomas, M.G., Burkart, M.D., and Walsh, C.T. 2002. Conversion of L-proline to pyrrolyl-2-carboxyl-S-PCP during undecylprodigiosin and pyoluteorin biosynthesis. Chem. Biol. 9: 171-184.[CrossRef][Medline] van Wezel, G.P., White, J., Bibb, M.J., and Postma, P.W. 1997. The malEFG gene cluster of Streptomyces coelicolor A3(2): Characterization, disruption and transcriptional analysis. Mol. Gen. Genet. 254: 604-608.[CrossRef][Medline]
Varma, A. and Palsson, B.Ø. 1994. Stoichiometric flux balance models quantitatively predict growth and metabolic by-product secretion in wild-type Escherichia coli W3110. Appl. Environ. Microbiol. 60: 3724-3731. Yassin, A.F., Brzezinka, H., Schaal, K.P., Truper, H.G., and Pulverer, G. 1988. Menaquinone composition in the classification and identification of aerobic actinomycetes. Zentralbl. Bakteriol. Mikrobiol. Hyg. 267: 339-356.
Zhang, Y.X., Tang, L., and Hutchinson, C.R. 1996. Cloning and characterization of a gene (msdA) encoding methylmalonic acid semialdehyde dehydrogenase from Streptomyces coelicolor. J. Bacteriol. 178: 490-495.
ftp://ftp.genome.ad.jp/pub/kegg/pathways/sco/; Streptomyces coelicolor KEGG pathway database (on ftp server). http://dbkweb.ch.umist.ac.uk/StreptoBASE/s_coeli/referencegel/; Streptomyces coelicolor 2D gel protein database. http://www.expasy.org/cgi-bin/search-biochem-index; ExPASy Biochemical Pathways database. http://www.expasy.org/enzyme; ExPASy Enzymes nomenclature database. http://www.expasy.org/sprot/sprot-top.html; SWISS-PROT protein knowledgebase. http://www.genome.ad.jp/dbget-bin/get_htext?S.coelicolor.kegg+-f+T+w+C; Streptomyces coelicolor KEGG Pathways database. http://www.genome.ad.jp/kegg/ligand.html; KEGG Ligand database. http://www.sanger.ac.uk/Projects/S_coelicolor/scheme.shtml; The Wellcome Trust Sanger Institute database of Streptomyces coelicolor. http://www.sanger.ac.uk/Software/Pfam/; Protein families database of alignments and HMMs.
Received October 15, 2004; accepted in revised format March 1, 2005. |